Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19870
Title: Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity.
Austin Authors: Vallejo-Ardila, Dora L;Fifis, Theodora;Burrell, Louise M ;Walsh, Katrina;Christophi, Christopher 
Affiliation: Cardiology
Surgery (University of Melbourne)
Medicine (University of Melbourne)
Issue Date: 26-Oct-2018
Date: 2018-10-26
Publication information: Oncotarget 2018; 9(84): 35500-35511
Abstract: Renin-angiotensin system inhibitors (RASi) have shown potential anti-tumor effects that may have a significant impact in cancer therapy. The components of the renin-angiotensin system (RAS) including both, conventional and alternative axis, appear to have contradictory effects on tumor biology. The mechanisms by which RASi impair tumor growth extend beyond their function of modulating tumor vasculature. The major focus of this review is to analyze other mechanisms by which RASi reprogram the tumor immune microenvironment. These involve impairing hypoxia and acidosis within the tumor stroma, regulating inflammatory signaling pathways and oxidative stress, modulating the function of the non-cellular components and immune cells, and regulating the cross-talk between kalli krein kinin system and RAS.
URI: https://ahro.austin.org.au/austinjspui/handle/1/19870
DOI: 10.18632/oncotarget.26174
ORCID: 0000-0003-1863-7539
Journal: Oncotarget
PubMed URL: 30464806
Type: Journal Article
Subjects: anti-tumor immunity
kallikrein kinin system
renin-angiotensin system
tumor microenvironment
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.